Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.07%54.76B | 10.30%222.58B | 10.42%53.65B | 1.72%201.79B | 16.28%52.04B | 1.86%51.85B | -9.38%49.32B | 0.60%48.58B | 7.35%198.38B | -4.19%44.75B |
| Cost of revenue | 4.84%38.19B | 7.55%151.1B | 6.33%36.43B | 6.73%140.49B | 16.65%36.15B | 4.48%35.16B | -2.14%34.92B | 9.45%34.26B | 8.93%131.63B | 0.11%30.99B |
| Gross profit | -3.78%16.57B | 16.61%71.48B | 20.19%17.22B | -8.17%61.3B | 15.44%15.89B | -3.26%16.68B | -23.17%14.4B | -15.71%14.33B | 4.35%66.75B | -12.63%13.77B |
| Operating expense | 4.73%12.2B | -5.34%51.08B | -2.87%11.65B | 19.27%53.96B | 11.86%12.67B | 47.65%17.34B | 3.47%11.97B | 12.97%11.99B | 5.43%45.25B | -5.99%11.32B |
| Selling and administrative expenses | ---- | -5.34%51.08B | ---- | 19.27%53.96B | ---- | ---- | ---- | ---- | 5.43%45.25B | ---- |
| -Selling and marketing expense | ---- | 2.44%20.85B | ---- | 5.27%20.35B | ---- | ---- | ---- | ---- | 2.76%19.34B | ---- |
| -General and administrative expense | ---- | -10.05%30.23B | ---- | 29.71%33.61B | ---- | ---- | ---- | ---- | 7.52%25.91B | ---- |
| Operating profit | -21.58%4.37B | 178.03%20.4B | 138.65%5.57B | -65.88%7.34B | 32.04%3.23B | -111.94%-657M | -66.10%2.43B | -63.42%2.33B | 2.16%21.51B | -34.16%2.44B |
| Net non-operating interest income (expenses) | -104.26%-6M | -4.75%682M | 24.78%141M | 64.98%716M | 77.03%262M | 28.13%123M | 77.24%218M | 68.66%113M | 352.08%434M | 196.00%148M |
| Non-operating interest income | -41.13%136M | 7.47%906M | 44.38%231M | 56.98%843M | 65.38%258M | 40.00%210M | 53.57%215M | 75.82%160M | 201.69%537M | 183.64%156M |
| Non-operating interest expense | 57.78%142M | 76.38%224M | 91.49%90M | 23.30%127M | -150.00%-4M | 61.11%87M | -117.65%-3M | 95.83%47M | 25.61%103M | 60.00%8M |
| Net investment income | -128.87%-466M | -75.55%953M | 16.96%1.61B | 268.34%3.9B | 594.53%1.54B | 81.99%-226M | 102.86%1.21B | -32.02%1.38B | -24.91%1.06B | -153.81%-311M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 249.44%2.13B | 147.09%1.24B | -1,002.53%-1.43B | -1,740.99%-2.64B | 195.58%238M | -976.27%-3.62B | 19,466.67%581M | 158M | 216.67%161M | 5.68%-249M |
| Income from associates and other participating interests | 230.65%81M | -85.16%61M | -140.79%-62M | 208.16%411M | 170.61%322M | -284.29%-129M | 340.00%66M | 1,788.89%152M | -280.95%-380M | -647.54%-456M |
| Special income (charges) | 3.63%-186M | 44.66%-1.5B | -6.04%-193M | -16.13%-2.71B | 3.41%-2.35B | -156.20%-154M | 58.33%-30M | -68.52%-182M | -441.17%-2.34B | -827.86%-2.43B |
| Less:Other special charges | -3.63%186M | 2,141.79%1.5B | 6.04%193M | -68.10%67M | -173.68%-224M | 154.38%149M | -155.56%-40M | 68.52%182M | 127.06%210M | 77.78%304M |
| Less:Write off | ---- | --0 | ---- | 24.45%2.65B | 20.92%2.57B | --5M | ---- | ---- | 2,237.36%2.13B | --2.13B |
| Other non-operating income (expenses) | 500.00%90M | -16.92%167M | -92.50%15M | -62.15%201M | -224.15%-257M | -35.53%49M | 148.81%209M | 21.95%200M | 37.21%531M | 120.21%207M |
| Income before tax | 6.26%6.01B | 205.44%22.01B | 36.20%5.66B | -65.64%7.21B | 559.01%2.98B | -189.14%-4.61B | -40.84%4.69B | -51.27%4.16B | -11.51%20.97B | -116.87%-649M |
| Income tax | -18.30%1.7B | 46.33%4.43B | 40.75%2.08B | -48.96%3.03B | 524.49%1.68B | -213.44%-1.37B | -51.83%1.24B | -42.20%1.48B | -8.15%5.93B | -155.38%-396M |
| Net income | 20.49%4.32B | 320.63%17.58B | 33.71%3.58B | -72.22%4.18B | 611.02%1.3B | -181.75%-3.25B | -35.54%3.45B | -55.15%2.68B | -12.77%15.04B | -108.12%-254M |
| Net income continuous operations | 20.49%4.32B | 320.65%17.58B | 33.69%3.58B | -72.22%4.18B | 613.04%1.3B | -181.77%-3.25B | -35.56%3.45B | -55.14%2.68B | -12.77%15.04B | -108.08%-253M |
| Noncontrolling interests | 60.00%24M | 4.55%69M | -16.67%15M | 15.79%66M | 366.67%14M | 54.55%17M | -37.04%17M | 12.50%18M | -9.52%57M | -62.50%3M |
| Net income attributable to the company | 20.36%4.29B | 325.67%17.51B | 34.01%3.57B | -72.55%4.11B | 599.61%1.28B | -182.40%-3.26B | -35.56%3.43B | -55.33%2.66B | -12.79%14.98B | -108.23%-257M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 20.36%4.29B | 325.67%17.51B | 34.01%3.57B | -72.55%4.11B | 599.61%1.28B | -182.40%-3.26B | -35.56%3.43B | -55.33%2.66B | -12.79%14.98B | -108.23%-257M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 26.81%27.29 | 332.14%107.17 | 34.00%21.52 | -72.25%24.8 | 714.29%7.74 | -183.46%-19.68 | -34.62%20.68 | -54.65%16.06 | -12.13%89.36 | -106.77%-1.26 |
| Diluted earnings per share | 26.81%27.29 | 332.27%107.16 | 34.16%21.52 | -72.25%24.79 | 709.45%7.74 | -183.46%-19.68 | -34.60%20.68 | -54.69%16.04 | -12.12%89.33 | -106.84%-1.27 |
| Dividend per share | 0 | 33.33%60 | 0 | 0.00%45 | -10.00%22.5 | 0 | 12.50%22.5 | 0 | 12.50%45 | 0.00%25 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |